摘要
VTE of the main treatment for anticoagulant therapy, anticoagulant therapy drug of choice for low molecular weight heparin (LMWH) for the overwhelming majority of clinicians agree that long-term oral anticoagulant therapy is still Vit.K antagonist (mainly warfarin).
VTE of the main treatment for anticoagulant therapy, anticoagulant therapy drug of choice for low molecular weight heparin （LMWH） for the overwhelming majority of clinicians agree that long- term oral anticoagulant therapy is still Vit. K antagonist （ mainly warfarin）.
出处
《血栓与止血学》
2009年第2期51-52,共2页
Chinese Journal of Thrombosis and Hemostasis
关键词
静脉疾病
临床
治疗
疗效
Venous thromboembolism（ VTE）
Anticoagulant therapy
